{"681189":{"#nid":"681189","#data":{"type":"external_news","title":"New Glaucoma Treatment May Save Vision","body":[{"value":"\u003Cp dir=\u0022ltr\u0022\u003EFour million Americans suffer from glaucoma, an incurable eye disease that slowly degrades peripheral vision and eventually leads to blindness. A new treatment could potentially stop this degradation and possibly save people\u2019s vision before it\u2019s too late.\u003C\/p\u003E\u003Cp dir=\u0022ltr\u0022\u003E\u003Ca href=\u0022https:\/\/chemistry.gatech.edu\/people\/raquel-lieberman\u0022\u003ERaquel Lieberman\u003C\/a\u003E, a professor in the School of Chemistry and Biochemistry and the Parker H. Petit Institute for Bioengineering and Bioscience, and her lab team have discovered two new antibodies with promise to treat glaucoma. The antibodies can break down the protein myocilin, which, when it malfunctions, can cause glaucoma.\u003C\/p\u003E\u003Cp\u003ELieberman\u2019s group recently published this research in the\u0026nbsp;\u003Ca href=\u0022https:\/\/doi.org\/10.1093\/pnasnexus\/pgae556\u0022\u003E\u003Cem\u003EProceedings of the National Academy of Sciences: Nexus\u003C\/em\u003E\u003C\/a\u003E.\u003C\/p\u003E","summary":"","format":"limited_html"}],"field_subtitle":"","field_summary":[{"value":"\u003Cp dir=\u0022ltr\u0022\u003EFour million Americans suffer from glaucoma, an incurable eye disease that slowly degrades peripheral vision and eventually leads to blindness. A new treatment could potentially stop this degradation and possibly save people\u2019s vision before it\u2019s too late.\u003C\/p\u003E\u003Cp dir=\u0022ltr\u0022\u003E\u003Ca href=\u0022https:\/\/chemistry.gatech.edu\/people\/raquel-lieberman\u0022\u003ERaquel Lieberman\u003C\/a\u003E, a professor in the School of Chemistry and Biochemistry and the Parker H. Petit Institute for Bioengineering and Bioscience, and her lab team have discovered two new antibodies with promise to treat glaucoma. The antibodies can break down the protein myocilin, which, when it malfunctions, can cause glaucoma.\u003C\/p\u003E\u003Cp\u003ELieberman\u2019s group recently published this research in the\u0026nbsp;\u003Ca href=\u0022https:\/\/doi.org\/10.1093\/pnasnexus\/pgae556\u0022\u003E\u003Cem\u003EProceedings of the National Academy of Sciences: Nexus\u003C\/em\u003E\u003C\/a\u003E.\u003C\/p\u003E","format":"limited_html"}],"field_summary_sentence":"","uid":"36583","created_gmt":"2025-03-17 19:59:51","changed_gmt":"2025-03-18 18:31:17","author":"lvidal7","boilerplate_text":"","field_publication":"","publication":"Futurity","field_article_url":"","publication_url":"https:\/\/www.futurity.org\/glaucoma-treatment-3272142\/","dateline":{"date":"2025-03-04T00:00:00-05:00","iso_date":"2025-03-04T00:00:00-05:00","tz":"America\/New_York"},"extras":[],"groups":[{"id":"1278","name":"College of Sciences"},{"id":"85951","name":"School of Chemistry and Biochemistry"}],"categories":[{"id":"138","name":"Biotechnology, Health, Bioengineering, Genetics"},{"id":"141","name":"Chemistry and Chemical Engineering"},{"id":"135","name":"Research"},{"id":"134","name":"Student and Faculty"}],"keywords":[{"id":"4896","name":"College of Sciences"},{"id":"17401","name":"Glaucoma"},{"id":"166928","name":"School of Chemistry and Biochemistry"}],"core_research_areas":[],"news_room_topics":[],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[],"email":[],"slides":[],"orientation":[],"userdata":""}}}